Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (part II)

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 1188-1200

  Wang, Fuzhou ^a,b   Stefano, George B ^c   Kream, Richard M ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Division of Neuroscience Bonoi Academy of Science and Education   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Chronic pain; Complex regional pain syndromes; Epigenomics; Ganglia, Spinal; Peripheral nerve injuries

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP; CYCLIC GMP; G PROTEIN COUPLED RECEPTOR KINASE 2; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; NEUROKININ 1 RECEPTOR; NOTCH RECEPTOR; NUCLEAR TRANSCRIPTION FACTOR; OXYTOCIN; PROSTAGLANDIN E2; PROTEIN KINASE; PURINERGIC P2X3 RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; G PROTEIN COUPLED RECEPTOR;

ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; PERIPHERAL NERVE INJURY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINAL GANGLION; COMPLEX REGIONAL PAIN SYNDROMES; COMPLICATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; METABOLISM; NERVOUS SYSTEM INJURY; PHYSIOLOGY;

BRAIN-DERIVED NEUROTROPHIC FACTOR; COMPLEX REGIONAL PAIN SYNDROMES; EPIGENESIS, GENETIC; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HUMANS; OXYTOCIN; PROTEIN KINASES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRAUMA, NERVOUS SYSTEM;

EID: 84904328521     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.890707     Document Type: Article

References (94)

1. Inbar-Feigenberg M, Choufani S, Butcher DT et al: Basic concepts of epigenetics. Fertil Steril, 2013; 99: 607-15
2. Wang F, Stefano GB, Kream RM: Epigenetic modifcation of drg neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (Part I). Med Sci Monit, 2014; 22: 1067-77
3. Aley KO, Levine JD: Role of protein kinase A in the maintenance of infammatory pain. J Neurosci, 1999; 19: 2181-86
4. Tumati S, Roeske WR, Largent-Milnes TM et al: Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats. J Neurosci Methods, 2011; 199: 62-68
5. Jeske NA, Diogenes A, Ruparel NB et al: A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain, 2008; 138: 604-16
6. Ritter DM, Ho C, O'Leary ME, Covarrubias M: Modulation of Kv3.4 channel N-type inactivation by protein kinase C shapes the action potential in dorsal root ganglion neurons. J Physiol, 2012; 590: 145-61
7. Kakimura J, Zheng T, Uryu N, Ogata N: Regulation of the spontaneous augmentation of Na(V)1.9 in mouse dorsal root ganglion neurons: efect of PKA and PKC pathways. Mar Drugs, 2010; 8: 728-40
8. Cang CL, Zhang H, Zhang YQ, Zhao ZQ: PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons. Mol Pain, 2009; 5: 33
9. Huang ZJ, Li HC, Liu S, Song XJ: Activation of cGMP-PKG signaling pathway contributes to neuronal hyperexcitability and hyperalgesia after in vivo prolonged compression or in vitro acute dissociation of dorsal root ganglion in rats. Sheng Li Xue Bao, 2012; 64: 563-76
10. Ferrari LF, Bogen O, Alessandri-Haber N et al: Transient decrease in nociceptor GRK2 expression produces long-term enhancement in infammatory pain. Neuroscience, 2012; 222: 392-403
11. Eijkelkamp N, Wang H, Garza-Carbajal A et al: Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/ Rap1, protein kinase Cepsilon, and MEK/ERK. J Neurosci, 2010; 30: 12806-15
12. 2+/calmodulin-dependent protein kinase II after peripheral nerve injury. Mol Pain, 2009; 5: 22
13. 2+ currents in rat primary afferent neurons: role of CaMKII and the effect of injury. J Neurosci, 2012; 32: 11737-11749
14. Cruz Duarte P, St-Jacques B, Ma W: Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model. Exp Neurol, 2012; 234: 466-81
15. Calvo M, Zhu N, Grist J, Ma Z et al: Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia, 2011; 59: 554-68
16. Gao YJ, Ji RR: c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? Open Pain J, 2009; 2: 11-17
17. Ma W, Quirion R: Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain, 2002; 99: 175-84
18. Wang W, Mei XP, Wei YY et al: Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain. Brain Behav Immun, 2011; 25: 1355-66
19. Manassero G, Repetto IE, Cobianchi S et al: Role of JNK isoforms in the development of neuropathic pain following sciatic nerve transection in the mouse. Mol Pain, 2012; 8: 39
20. Hervera A, Leánez S, Pol O: The inhibition of the nitric oxide-cGMP-PKGJNK signaling pathway avoids the development of tolerance to the local antiallodynic efects produced by morphine during neuropathic pain. Eur J Pharmacol, 2012; 685: 42-51
21. Smith MT, Woodruf TM, Wyse BD et al: A small molecule angiotensin ii type 2 receptor antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia. Pain Med, 2013; 14: 1557-68
22. Ndong C, Landry RP, DeLeo JA, Romero-Sandoval EA: Mitogen activated protein kinase phosphatase-1 prevents the development of tactile sensitivity in a rodent model of neuropathic pain. Mol Pain, 2012; 8: 34
23. Wang F, Wu H, Xu S et al: Macrophage migration inhibitory factor activates cyclooxygenase 2-prostaglandin E2 in cultured spinal microglia. Neurosci Res, 2011; 71: 210-18
24. Trang T, Beggs S, Wan X, Salter MW: P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci, 2009; 29: 3518-28
25. Sun YG, Gracias NG, Drobish JK et al: The c-kit signaling pathway is involved in the development of persistent pain. Pain, 2009; 144: 178-86
26. Chini B, Parenti M, Poyner DR, Wheatley M: G-protein-coupled receptors: from structural insights to functional mechanisms. Biochem Soc Trans, 2013; 41: 135-36
27. Zhang YK, Huang ZJ, Liu S et al: WNT signaling underlies the pathogenesis of neuropathic pain in rodents. J Clin Invest, 2013; 123: 2268-86
28. El Bejjani R, Hammarlund M: Notch signaling inhibits axon regeneration. Neuron, 2012; 73: 268-78
29. Hashimoto M, Ishii K, Nakamura Y et al: Neuroprotective efect of sonic hedgehog up-regulated in Schwann cells following sciatic nerve injury. J Neurochem, 2008; 107: 918-27
30. Kotani T: Protein kinase A activity and Hedgehog signaling pathway. Vitam Horm, 2012; 88: 273-91
31. Babcock DT, Shi S, Jo J et al: Hedgehog signaling regulates nociceptive sensitization. Curr Biol, 2011; 21: 1525-33
32. Sun T, Luo J, Jia M et al: Small interfering RNA-mediated knockdown of NF-kBp65 attenuates neuropathic pain following peripheral nerve injury in rats. Eur J Pharmacol, 2012; 682: 79-85
33. Inoue G, Ochiai N, Ohtori S et al: Injection of nuclear factor-kappa B decoy into the sciatic nerve suppresses mechanical allodynia and thermal hyperalgesia in a rat infammatory pain model. Spine (Phila Pa 1976), 2006; 31: 2904-8
34. Kanngiesser M, Häussler A, Myrczek T et al: Inhibitor kappa B kinase beta dependent cytokine upregulation in nociceptive neurons contributes to nociceptive hypersensitivity after sciatic nerve injury. J Pain, 2012; 13: 485-97
35. Yang RH, Strong JA, Zhang JM: NF-kappaB mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons. Mol Pain, 2009; 5: 26
36. de Mos M, Laferrière A, Millecamps M et al: Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I). J Pain, 2009; 10: 1161-69
37. Cai YQ, Chen SR, Pan HL: Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain. J Pharmacol Exp Ther, 2013; 345: 161-68
38. Descalzi G, Fukushima H, Suzuki A et al: Genetic enhancement of neuropathic and infammatory pain by forebrain upregulation of CREB-mediated transcription. Mol Pain, 2012; 8: 90
39. Ma W, Hatzis C, Eisenach JC: Intrathecal injection of cAMP response element binding protein (CREB) antisense oligonucleotide attenuates tactile allodynia caused by partial sciatic nerve ligation. Brain Res, 2003; 988: 97-104
40. Xu S, Wu H, Wang X et al: Tumor suppressor menin mediates peripheral nerve injury-induced neuropathic pain through potentiating synaptic plasticity. Neuroscience, 2012; 223: 473-85
41. Shen X, Liu Y, Xu S et al: Menin regulates spinal glutamate-GABA balance through GAD65 contributing to neuropathic pain. Pharmacol Rep, 2014; 66: 49-55
42. Imler JL, Wasylyk B: AP1, a composite transcription factor implicated in abnormal growth control. Prog Growth Factor Res, 1989; 1: 69-77
43. Mucha M, Ooi L, Linley JE et al: Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J Neurosci, 2010; 30: 13235-45
44. Tachibana T, Noguchi K, Ruda MA: Analysis of gene expression following spinal cord injury in rat using complementary DNA microarray. Neurosci Lett, 2002; 327: 133-37
45. Kalmar B, Greensmith L, Malcangio M et al: The efect of treatment with BRX-220, a co-inducer of heat shock proteins, on sensory fbers of the rat following peripheral nerve injury. Exp Neurol, 2003; 184: 636-47
46. Hsieh YL, Chou LW, Chang PL et al: Low-level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury: possible involvements in hypoxia-inducible factor 1a (HIF-1a). J Comp Neurol, 2012; 520: 2903-16
47. Shenaq M, Kassem H, Peng C et al: Neuronal damage and functional defcits are ameliorated by inhibition of aquaporin and HIF1a after traumatic brain injury (TBI). J Neurol Sci, 2012; 323: 134-40
48. Chavez JC, Almhanna K, Berti-Mattera LN: Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats. Neurosci Lett, 2005; 374: 179-82
49. Rivera-Arconada I, Benedet T, Roza C et al: DREAM regulates BDNF-dependent spinal sensitization. Mol Pain, 2010; 6: 95
50. Matayoshi S, Jiang N, Katafuchi T et al: Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during infammation in the rat. J Physiol, 2005; 569: 685-95
51. Canudas AM, Pezzi S, Canals JM et al: Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury. Brain Res Mol Brain Res, 2005; 134: 147-5452.
52. Cao XH, Byun HS, Chen SR et al: Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J Neurochem, 2010; 114: 1460-75
53. Hayashida K, Clayton BA, Johnson JE, Eisenach JC: Brain derived nerve growth factor induces spinal noradrenergic fber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain, 2008; 136: 348-55
54. Hayashida K, Eisenach JC: Spinal alpha 2-adrenoceptor-mediated analgesia in neuropathic pain refects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function. Anesthesiology, 2010; 113: 406-12
55. Melemedjian OK, Tillu DV, Asiedu MN et al: BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state. Mol Pain, 2013; 9: 12
56. Biggs JE, Lu VB, Stebbing MJ et al: Is BDNF sufcient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Mol Pain, 2010; 6: 44
57. Uchida H, Matsushita Y, Ueda H: Epigenetic regulation of BDNF expression in the primary sensory neurons after peripheral nerve injury: implications in the development of neuropathic pain. Neuroscience, 2013; 240: 147-54
58. Kai-Kai MA, Anderton BH, Keen P: A quantitative analysis of the interrelationships between subpopulations of rat sensory neurons containing arginine vasopressin or oxytocin and those containing substance P, fuorideresistant acid phosphatase or neuroflament protein. Neuroscience, 1986; 18: 475-86
59. Ayar A, Ozcan M, Alcin E et al: Oxytocin activates calcium signaling in rat sensory neurons through a protein kinase C-dependent mechanism. J Physiol Biochem, 2014; 70: 43-48
60. Schorscher-Petcu A, Sotocinal S, Ciura S et al: Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci, 2010; 30: 8274-84
61. Juif PE, Breton JD, Rajalu M et al: Long-lasting spinal oxytocin analgesia is ensured by the stimulation of allopregnanolone synthesis which potentiates GABAA receptor-mediated synaptic inhibition. J Neurosci, 2013; 33: 16617-26
62. Yang J, Liang JY, Zhang XY et al: Oxytocin, but not arginine vasopressin is involving in the antinociceptive role of hypothalamic supraoptic nucleus. Peptides, 2011; 32: 1042-46
63. Juif PE, Poisbeau P: Neurohormonal efects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats. Pain, 2013; 154: 1449-56
64. Russo R, D'Agostino G, Mattace Raso G et al: Central administration of oxytocin reduces hyperalgesia in mice: implication for cannabinoid and opioid systems. Peptides, 2012; 38: 81-88
65. Kumsta R, Hummel E, Chen FS, Heinrichs M: Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience. Front Neurosci, 2013; 7: 83
66. Uchida H, Sasaki K, Ma L, Ueda H: Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience, 2010; 166: 1-4
67. Rose K, Ooi L, Dalle C et al: Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain, 2011; 152: 742-54
68. Zhao X, Tang Z, Zhang H et al: A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary aferent neurons. Nat Neurosci, 2013; 16: 1024-31
69. Uchida H, Ma L, Ueda H: Epigenetic gene silencing underlies C-fber dysfunctions in neuropathic pain. J Neurosci, 2010; 30: 4806-14
70. Matsushita Y, Araki K, Omotuyi OI et al: HDAC inhibitors restore C-fbre sensitivity in experimental neuropathic pain model. Br J Pharmacol, 2013; 170: 991-98
71. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K: MicroRNAs and epigenetics. FEBS J, 2011; 278: 1598-609
72. Chiechio S, Copani A, De Petris L et al: Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Mol Pain, 2006; 2: 20
73. Van Buyten JP, Smet I, Liem L et al: Treatment of CRPS with spinal cord stimulation of the dorsal root ganglion: a case series. MK0009A-EN 2012; 2012: 1-6
74. Kanno T, Yaguchi T, Nishizaki T: Noradrenaline stimulates ATP release from DRG neurons by targeting beta(3) adrenoceptors as a factor of neuropathic pain. J Cell Physiol, 2010; 224: 345-51
75. Wang YJ, Li XF, Ding F et al: Noradrenaline regulates substance P release from rat dorsal root ganglion neurons in vitro. Neurosci Bull, 2011; 27: 300-6
76. Li Y, He J, Sui S et al: Clenbuterol upregulates histone demethylase JHDM2a via the b2-adrenoceptor/cAMP/PKA/p-CREB signaling pathway. Cell Signal, 2012; 24: 2297-306
77. Michelotti GA, Brinkley DM, Morris DP et al: Epigenetic regulation of human alpha1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation. FASEB J, 2007; 21: 1979-93
78. Herradon G, Ezquerra L, Nguyen T et al: Noradrenergic and opioidergic alterations in neuropathy in diferent rat strains. Neurosci Lett, 2008; 438: 186-89
79. Klega A, Eberle T, Buchholz HG et al: Central opioidergic neurotransmission in complex regional pain syndrome. Neurology, 2010; 75: 129-36
80. Shin NY, Kang DH, Jang JH et al: Impaired recognition of social emotion in patients with complex regional pain syndrome. J Pain, 2013; 14: 1304-9
81. Flaisher-Grinberg S, Persaud SD, Loh HH, Wei LN: Stress-induced epigenetic regulation of k-opioid receptor gene involves transcription factor c-Myc. Proc Natl Acad Sci USA, 2012; 109: 9167-72
82. Thakor DK, Lin A, Matsuka Y et al: Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy. Mol Pain, 2009; 5: 14
83. Muizelaar JP, Kleyer M, Hertogs IA, DeLange DC: Complex regional pain syndrome (refex sympathetic dystrophy and causalgia): management with the calcium channel blocker nifedipine and/or the alpha-sympathetic blocker phenoxybenzamine in 59 patients. Clin Neurol Neurosurg, 1997; 99: 26-30
84. 2+ channel activity and nociceptive input in neuropathic pain. J Biol Chem, 2012; 287: 6002-13
85. Pollema-Mays SL, Centeno MV, Ashford CJ et al: Expression of background potassium channels in rat DRG is cell-specifc and down-regulated in a neuropathic pain model. Mol Cell Neurosci, 2013; 57C: 1-9
86. Kawano T, Zoga V, McCallum JB et al: ATP-sensitive potassium currents in rat primary aferent neurons: biophysical, pharmacological properties, and alterations by painful nerve injury. Neuroscience, 2009; 162: 431-43
87. Kung LH, Gong K, Adedoyin M et al: Evidence for glutamate as a neuroglial transmitter within sensory ganglia. PLoS One, 2013; 8: e68312
88. Li JY, Wang X, Ji PT et al: Peripheral nerve injury decreases the expression of metabolic glutamate receptor 7 in dorsal root ganglion neurons. Neurosci Lett, 2012; 531: 52-56
89. Hudson LJ, Bevan S, McNair K et al: Metabotropic glutamate receptor 5 upregulation in A-fbers after spinal nerve injury: 2-methyl-6-(phenylethynyl)- pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci, 2002; 22: 2660-68
90. Sunder RA, Toshniwal G, Dureja GP: Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury. J Brachial Plex Peripher Nerve Inj, 2008; 3: 22
91. Chiechio S, Copani A, Zammataro M et al: Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain. Trends Pharmacol Sci, 2010; 31: 153-60
92. Marutha Ravindran CR, Ticku MK: Role of CpG islands in the up-regulation of NMDA receptor NR2B gene expression following chronic ethanol treatment of cultured cortical neurons of mice. Neurochem Int, 2005; 46: 313-27
93. Naik AK, Pathirathna S, Jevtovic-Todorovic V: GABAA receptor modulation in dorsal root ganglia in vivo afects chronic pain after nerve injury. Neuroscience, 2008; 154: 1539-53
94. Lee JY, Fink DJ, Mata M: Vector-mediated gene transfer to express inhibitory neurotransmitters in dorsal root ganglion reduces pain in a rodent model of lumbar radiculopathy. Spine (Phila Pa 1976), 2006; 31: 1555-58